SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging following a strong quarterly earnings report that highlighted accelerating data center demand and robust guidance, sparking a massive rally and multiple analyst price target hikes. While the community is actively debating the sustainability of this AI-driven valuation, sentiment remains overwhelmingly bullish as traders weigh the company's competitive position in the high-performance CPU market against broader sector volatility.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing intense social media chatter as shareholders rally behind activist investor Himanshu Shahs call to vote against executive compensation and board re-elections due to persistent stock underperformance. Investors are aggressively speculating that pending partnership deals, particularly regarding Pfizers use of Matrix-M in pneumococcal vaccine development, could serve as the major catalyst needed to finally break the stock out of its long-term trading range.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors focus on the company's aggressive Bitcoin acquisition strategy and the upcoming Q1 earnings call, which community members are watching closely for guidance on capital allocation and potential asset sales. Sentiment remains heavily divided, with bulls pointing to the company's massive Bitcoin holdings as a leveraged play on crypto market momentum, while bears continue to raise concerns over high debt levels and recent dilution.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is experiencing a significant surge in investor attention and bullish sentiment, driven by analyst upgrades from Morgan Stanley that cite a favorable pivot toward AI data center infrastructure. The community is actively discussing the potential for a massive short squeeze and long-term valuation growth, with many investors maintaining a strong conviction in the stock's future performance as a key player in the energy-intensive AI sector.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting investor attention following the expansion of commercial payer coverage for its fibromyalgia treatment, TONMYA, which now includes millions of insured lives. While the community is actively debating the impact of these coverage wins on future revenue growth, sentiment remains polarized between optimistic shareholders focused on the drug's launch momentum and critics wary of the company's historical dilution and capital-raising patterns.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing heightened community speculation regarding a potential buyout, fueled by unusual trading patterns, institutional accumulation, and a historical tendency for the stock to consolidate before significant news. Investors remain focused on the company's long-term Orladeyo revenue growth and potential pipeline advancements, while actively debating the impact of increased short interest and the strategic value of the HAE market.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors react to strong weekly prescription data for its Wegovy pill, which is outperforming competitor launches and helping revive sentiment around the company's growth outlook. Community discussion is focused on the potential for a share price recovery leading into upcoming earnings, as many investors argue the stock is deeply undervalued relative to its dominant market position in the GLP-1 sector.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Investors are actively debating the divergence between NVIDIA's stagnant price action and the explosive momentum seen in peers like AMD, with many interpreting the underperformance as a temporary rotation or market maker pinning ahead of upcoming earnings. While sentiment remains divided between those calling for a breakdown and others holding for a major breakout, the community is focused on whether NVIDIA's long-term dominance in AI infrastructure will eventually reclaim its leadership position.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is surging on renewed market optimism fueled by reports of potential diplomatic breakthroughs in the Iran conflict and sustained strength in the AI-driven tech sector. While traders are actively debating the sustainability of this rally and expressing frustration over market volatility, institutional sentiment remains robust as investors continue to rotate into equities despite concerns regarding global energy supplies and ongoing geopolitical tensions.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Semiconductor bears are feeling the intense pressure of a relentless, momentum-driven bull market that continues to ignore geopolitical risks and valuation concerns, leaving investors torn between capitulation and holding out for a long-awaited reversal. The community is actively debating the sustainability of the current melt-up, with many traders frustrated by consistent after-hours rallies and a persistent disconnect between sector earnings and price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SC II Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on June 30, 2025 and is headquartered in New York, NY.

SC II Acquisition Corp. - Ordinary Shares - Class A

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Current Price	$10.00
Prev Close	$10.00
Open	$10.00
Dividend Yield	N/A
50-Day Moving Average	$9.99
Beta	0.00
Avg. Volume	39,133.57
PE Ratio	N/A

52-Week High	$10.07
52-Week Low	$9.90
Market Capitalization	$73.93M
EPS (Annual)	$0.0042
Price to Book	1.43
Revenue Per Employee	$0.00

SCII
SC II Acquisition Corp. - Ordinary Shares - Class A

Feed

News

Sentiment

Fundamentals

Info

Latest SCII News

SCIISC II Acquisition Corp. - Ordinary Shares - Class A